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LETTERS TO THE EDITOR
Exercise Testing and Survival After
Coronary Bypass Surgery
The report by Weineret al. (I) from the Coronary ArterySurgery
Study (CASS) registry regarding the influence of medical and
surgical therapyon survivalbasedon exercisetesting is potentially
of significant value in clinical decision making.
In the report, a Cox model(Table3) demonstrates nineclinical.
exerciseand angiographic variables in the overall study group that
are significantly associatedwith survival. Finalexercisestage (chi-
square = 16.2) is the only important exercise variable, ranked
seventh of nine based on the chi-square value. The variable with
the strongest association to survival is left ventricular score (chi-
square = 429.8). The authors identify a high risk group based on
exercise response (ischemic ST response and completion of stage
I or less of the Bruce protocol) in which survival is superior in
certain surgical subgroups (data summarized in Fig. 4 to 6).
The authors carefully point out that the two treatment groups
(medical and surgical) that constitute the entire study population
differ substantially with respect to important baseline variables.
They also point out that in analyzing survival in the various high
risk exercise SUbgroups, adjustment is not made for differences
among the subgroups with respect to the important predictors of
survival identified by the Cox model.
We are concernedthat withoutproperadjustment for important
determinants of survival like left ventricularfunction, the exercise
analysis as summarized in Figures 4 to 6 may not be valid. Other
factors that characterize these individual subgroups may be just as
important in inftuencing survival as the mode of therapy or the
high risk exercise response . For example. in the data summarized
in Figure 4, if the medically treated subgroup had a significantly
greaternumberof patientswith markedleft ventriculardysfunction
compared with the corresponding surgical subgroup. a survival
disadvantage for the subgroup would be anticipated . Indeed. by
combining data from Figures 4 and 6. it appears that 33% (III
of 334)of the medically treatedpatientswith the highriskexercise
response had a left ventricularscore > 10 whereasonly 22% (102
of 455) of the corresponding surgical group had a score > 10.
Thus, left ventricular dysfunction may be the major factor ac-
counting for the survival disadvantage of the medical subgroupin
Figure4. Similarbaselinedifferences maybe affecting thesurvival
curves in Figures 5 and 6.
Of critical concern to the clinician is whether the functional
response to exercise can help identify patients with three vessel
disease and normal left ventricular function as well as patients
with one or two vessel disease with abnormal left ventricular func-
tion whose survival may be enhanced by surgery. Unfonunately,
these important subgroups are not directly analyzed. If one tries
to glean an answer to this question from the data in Figures 5 and
6, conflicting answers are suggested dependingon which curve is
examined.
In summary , we do not believe it is valid to examine survival
on the basis of exercise response without adjusting for other im-
portant survival predictors. In addition. certain key subgroups re-
main to be analyzed.
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Reply
The purposeof our initial investigation was to test the hypothesis
that exercise testing is of value in identifying patients who would
benefit from coronary artery bypass surgery with improved sur-
vival. Not only was a small subset of patients characterized with
abnormal exercise test findings (the higher risk subgroup) whose
survival was enhanced by surgery, but also, most importantly. a
larger subset of patients was identified with different exercise test
features (the lower risk subgroup) whose survival was not pro-
longed by surgery. We attempted to stratify patients by the two
most important nonexercise test predictors of survival. the number
of diseased coronary vessels and the left ventricularfunction but,
as pointed out, we did not combine these two important angio-
graphic descriptors to describe other subgroups. One must take
into account the statistical limitations of retrospectively subgroup-
ing patientsand comparingmultiple subsets. In addition, the num-
bers of patientsin each subgroup are often too small to allow strict
comparison. This latter problem precluded a meaningful compar-
ison of the medical and surgical results in patients with one and
two vessel coronary artery disease and abnormal left ventricular
function .
We have begun a more extensive analysis of 1,249 patients
with three vessel coronaryartery disease stratified by both the left
ventricular function and exercise test findings and have reported
our preliminary observations (I). This subgroup of patients with
three vessel coronarydisease is an important subset becausethese
patientsare usuallynot candidatesfor coronaryangioplasty . More-
over. the recent finding from the CASS randomized trial (2). that
patients with three vessel coronarydisease and impaired left ven-
tricular function have a survival advantage after surgical therapy,
has majoreconomic implications regarding the indications for car-
diac catheterization. In this investigation. however, the patients
were not further stratified by the exercise test results. We hope to
have meaningful results soon.
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